Xiaolong Qi, M.D., Professor of Medicine

Founder and Chair, Liver Health Consortium in China (CHESS)

Editor-in-Chief, Portal Hypertension & Cirrhosis

Chief, Center of Liver Disease, Zhongda Hospital, Southeast University, China

Focused on the research and transformation of new technologies for the diagnosis and treatment of major chronic liver diseases, published SCI papers with a cumulative impact factor of 2300.1 points, cited 10409 times, and an H-index of 56 (Google scholar)，53 (Scopus)

Sole corresponding authors: Lancet Gastroenterol Hepatol, J Hepatol, Gut, Hepatology, Radiology

Co corresponding author: Nature Medicine, Co first author: BMJ. Led the development of 5 consensus guidelines, Won the Rising Star Award from Asian-Pacific Association for the Study of the Liver, Won the first prize of Jiangsu Provincial Science and Technology Award (First Completer), Won Young Science and Technology Award of China Medical Science and Technology Award (First Completer).